KPTI
Karyopharm Therapeutics Inc.
0.00 (0.00%)1.70USD424K成交股數38.6M市值–本益比(近四季)0.3股價營收比-11.9%營收年增(近四季)2026-11-03下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 33.4M+11% | 35.1M+15% | 44.0M+14% | 37.9M-11% | 30.0M-9% | 30.5M-15% | 38.8M+3% | 42.8M+11% | 33.1M | 36.0M | 37.6M | 38.7M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 29.0M | 33.8M | 30.5M | 32.8M | 34.6M | 33.3M | 36.1M | 38.4M | 35.4M | 35.6M | 31.5M | 32.3M |
| 銷售管理費用 | 25.9M | 26.7M | 26.6M | 28.5M | 27.4M | 27.2M | 27.6M | 31.1M | 29.5M | 30.8M | 34.5M | 35.9M |
| 營業利益 | −22.5M-32% | −26.8M-14% | −15.2M-42% | −24.4M-13% | −33.3M-1% | −31.3M+0% | −26.3M-11% | −28.1M-9% | −33.8M | −31.3M | −29.6M | −30.9M |
| 營業利益率 | -67.4% | -76.3% | -34.6% | -64.3% | -110.8% | -102.4% | -67.8% | -65.7% | -101.9% | -86.8% | -78.7% | -79.8% |
| 稅後淨利 | −67.0M+186% | −22.4M-27% | −33.1M+3% | −37.3M-257% | −23.5M-37% | −30.8M-11% | −32.1M-2% | 23.8M-170% | −37.4M | −34.5M | −32.6M | −34.1M |
| 淨利率 | -200.5% | -63.9% | -75.2% | -98.2% | -78.2% | -100.8% | -82.7% | 55.6% | -112.8% | -95.8% | -86.8% | -88.2% |
| 稀釋 EPS | -2.32-16% | -1.24-47% | -3.82-1% | -4.32+45% | -2.77-43% | -2.33+677% | -3.85+1228% | -2.97+890% | -4.85 | -0.30 | -0.29 | -0.30 |
| 稀釋股數 | 28.9K | 24.7K | 8.7K | 8.6K | 8.5K | 8.5K | 8.3K | 10.3K | 7.7K | 114K | 114M | 113M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 55.0M | 90.9M | 37.7M | 38.7M | 38.8M | 62.5M | 72.8M | 84.8M | 30.6M | 43.7M | 80.9M | 84.1M |
| 應收帳款 | 29.9M | 23.4M | 31.9M | 32.9M | 35.2M | 30.8M | 31.8M | 38.0M | 31.1M | 37.9M | 32.3M | 35.2M |
| 存貨 | 4.0M | 3.6M | 4.0M | 5.0M | 4.8M | 4.7M | 4.7M | 3.5M | 2.8M | 3.1M | 3.7M | 3.8M |
| 總資產 | 111M | 131M | 96.2M | 105M | 128M | 164M | 189M | 214M | 204M | 270M | 298M | 326M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 441M | 397M | 365M | 344M | 334M | 350M | 349M | 346M | 373M | 370M | 369M | 371M |
| 股東權益 | −330M | −266M | −269M | −239M | −206M | −186M | −160M | −132M | −169M | −100M | −71.2M | −45.2M |
| 負債比 | 396.6% | 302.1% | 379.8% | 327.8% | 261.2% | 213.1% | 184.3% | 161.8% | 182.6% | 137.2% | 123.9% | 113.9% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −22.7M | – | – | −39.0M-11% | – | – | – | −43.7M | – | – | −18.9M |
| 資本支出 | – | – | – | – | 0 | – | – | – | 195K | – | – | 0 |
| 自由現金流 | – | – | – | – | −39.0M-11% | – | – | – | −43.9M | – | – | −18.9M |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | -129.9% | – | – | – | -132.6% | – | – | -48.9% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 146M
| 產品 | 115M | 78.6% | +1.8% |
|---|---|---|---|
| License And Other | 31.2M | 21.4% | -3.8% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 146M | +0.6% | −196M | -134.2% | -17.93 | −75.4M |
| FY2024 | 145M | -0.5% | −76.4M | -52.6% | -14.00 | −128M |
| FY2023 | 146M | -7.0% | −143M | -98.0% | -18.79 | −92.7M |
| FY2022 | 157M | -25.1% | −165M | -105.2% | -2.02 | −150M |
| FY2021 | 210M | +94.1% | −124M | -59.1% | -1.65 | −107M |
| FY2020 | 108M | +164.3% | −196M | -181.6% | -2.72 | −160M |
| FY2019 | 40.9M | +34.8% | −200M | -488.1% | -3.22 | −191M |
| FY2018 | 30.3M | – | −178M | -588.1% | -3.14 | −161M |